Teneligliptin/vildagliptinBullous pemphigoid: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1905卷 / 1期

关键词：

D O I：

10.1007/s40278-022-14854-6

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：464 / 464

相关论文

共 50 条

[41] TozinameranBullous pemphigoid: case report
Reactions Weekly, 2022, 1895 (1) : 352 - 352
[42] AtezolizumabBullous pemphigoid: case report
Reactions Weekly, 2025, 2056 (1) : 77 - 77
[43] CemiplimabBullous pemphigoid: case report
Reactions Weekly, 2022, 1916 (1) : 140 - 140
[44] AdalimumabBullous pemphigoid: case report
Reactions Weekly, 2021, 1853 (1) : 16 - 16
[45] NivolumabBullous pemphigoid: case report
Reactions Weekly, 2018, 1729 (1) : 192 - 192
[46] PembrolizumabBullous pemphigoid: case report
Reactions Weekly, 2017, 1653 (1) : 256 - 256
[47] PembrolizumabBullous pemphigoid: case report
Reactions Weekly, 2021, 1853 (1) : 387 - 387
[48] SecukinumabBullous pemphigoid: case report
Reactions Weekly, 2017, 1675 (1) : 196 - 196
[49] Dyshidrosiform pemphigoid: Report of a case
Sugimura, C
Katsuura, J
Moriue, T
Matsuoka, Y
Kubota, Y
JOURNAL OF DERMATOLOGY, 2003, 30 (07): : 525 - 529
[50] TozinameranBullous pemphigoid: case report
Reactions Weekly, 2022, 1918 (1) : 463 - 463

← 1 2 3 4 5 →